{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:38:44Z","timestamp":1775518724112,"version":"3.50.1"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review focuses on sharing the current and changing cystic fibrosis (CF) care model. This includes changes in CF care as a chronic disease with availability of new revolutionary, highly effective therapies as well as incorporation of shared decision-making, coproduction of care, quality improvement, telemedicine, and remote patient monitoring.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Changes in the CF management, the CF patient population, and CF care team are described as well as how CF care has adapted to these changes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>CF is a chronic, multisystem disease requiring a large specialized multidisciplinary care team for effective treatment. With improvements in CF care and new treatments, people with CF are living longer and healthier lives. As new issues arise, the CF team needs to adapt. This was highlighted by the introduction of highly effective cystic fibrosis transmembrane conductance regulator modulator therapy, which targets the cellular defect in CF, the COVID-19 pandemic, which lead to the incorporation of telehealth and remote patient monitoring into the CF care model, and the partnering with people with CF and families through shared decision-making and coproduction.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001286","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T11:04:31Z","timestamp":1692356671000},"page":"603-610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A new era in cystic fibrosis care: always changing and adapting"],"prefix":"10.1097","volume":"35","author":[{"given":"Barry L.","family":"Diener","sequence":"first","affiliation":[{"name":"Division of Pediatric Pulmonary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredy","family":"Huertero","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stony Brook Children's Hospital, Renaissance School of Medicine at Stony Brook University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Stables-Carney","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Hoelzer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stony Brook University Hospital, Stony Brook, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Kier","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"R1-20250730","first-page":"21","article-title":"Epidemiology of cystic fibrosis","author":"Walters","year":"2007","journal-title":"Cystic fibrosis"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3928\/19382359-20190327-01","article-title":"Review of cystic fibrosis","volume":"48","author":"Goetz","year":"2019","journal-title":"Pediatr Ann"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41598-019-42404-6","article-title":"Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools","volume":"9","author":"Pereira","year":"2019","journal-title":"Sci Rep"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1983","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20250730","first-page":"246","article-title":"Consensus report on nutrition for pediatric patients with cystic fibrosis","volume":"35","author":"Borowitz","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"R7-20250730","first-page":"56","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease","volume":"56","author":"Anderson","year":"1938","journal-title":"Am J Dis Child"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.lpm.2017.04.012","article-title":"The changing epidemiology and demography of cystic fibrosis","volume":"46","author":"Stephenson","year":"2017","journal-title":"Presse Med"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: a disease with a new face","volume":"109","author":"De Boeck","year":"2020","journal-title":"Acta Paediatr"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.2010-0910","article-title":"Children with medical complexity: an emerging population for clinical and research initiatives","volume":"127","author":"Cohen","year":"2011","journal-title":"Pediatrics"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-1489","article-title":"Guiding principles for team-based pediatric care","volume":"140","author":"Katkin","year":"2017","journal-title":"Pediatrics"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1542\/peds.2007-2875","article-title":"Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders","volume":"123","author":"Grosse","year":"2009","journal-title":"Pediatrics"},{"issue":"(Suppl 1)","key":"R16-20250730","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57 Suppl 1","author":"McBennett","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"(Suppl 1)","key":"R17-20250730","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","article-title":"European Cystic Fibrosis Society Standards of care: framework for the Cystic Fibrosis Centre","volume":"13","author":"Conway","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"(Suppl 1)","key":"R19-20250730","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1136\/bmjqs-2013-002369","article-title":"Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project","volume":"23","author":"Boyle","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4187\/002013209790983223","article-title":"Cystic fibrosis foundation: achieving the mission","volume":"54","author":"Marshall","year":"2009","journal-title":"Respir Care"},{"issue":"(Suppl 1)","key":"R21-20250730","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1136\/bmjqs-2013-002363","article-title":"Improving chronic care delivery and outcomes: the impact of the cystic fibrosis Care Center Network","volume":"23","author":"Mogayzel","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes11060589","article-title":"The changing epidemiology of cystic fibrosis: incidence, survival and impact of the CFTR Gene Discovery","volume":"11","author":"Scotet","year":"2020","journal-title":"Genes (Basel)"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chest.2022.07.004","article-title":"The changing epidemiology of cystic fibrosis: the implications for adult care","volume":"163","author":"Burgel","year":"2023","journal-title":"Chest"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1164\/rccm.201910-1943SO","article-title":"Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications","volume":"201","author":"Mall","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20250730","first-page":"e16144","article-title":"A review of Trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy","volume":"13","author":"Zaher","year":"2021","journal-title":"Cureus"},{"key":"R26-20250730","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073513","article-title":"The effect of CFTR modulators on airway infection in cystic fibrosis","volume":"23","author":"Harvey","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9092706","article-title":"CFTR modulators: impact on fertility, pregnancy, and lactation in women with cystic fibrosis","volume":"9","author":"Taylor-Cousar","year":"2020","journal-title":"J Clin Med"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10010023","article-title":"Real-world safety of CFTR modulators in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Dagenais","year":"2020","journal-title":"J Clin Med"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"17534666221144211","DOI":"10.1177\/17534666221144211","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on depression and anxiety in cystic fibrosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ppul.25859","article-title":"A survey: understanding the health and perspectives of people with CF not benefiting from CFTR modulators","volume":"57","author":"Kramer-Golinkoff","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/ppul.26101","article-title":"Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care","volume":"57","author":"Friedman","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijns6010008","article-title":"History of newborn screening for cystic fibrosis: the early years","volume":"6","author":"Travert","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"20","author":"Barben","year":"2021","journal-title":"J Cyst Fibros"},{"key":"R35-20250730","first-page":"CD013285","article-title":"Exercise versus airway clearance techniques for people with cystic fibrosis","volume":"6","author":"Heinz","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R36-20250730","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061216","article-title":"The changing landscape of nutrition in cystic fibrosis: the emergence of overweight and obesity","volume":"14","author":"Bailey","year":"2022","journal-title":"Nutrients"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jcf.2019.09.012","article-title":"EnVisioning the future: endocrinology in cystic fibrosis","volume":"18","author":"Brennan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"R42-20250730","first-page":"8","article-title":"Ivacaftor: a novel gene-based therapeutic approach for cystic fibrosis","volume":"18","author":"Condren","year":"2013","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s40265-013-0115-2","article-title":"Ivacaftor: a review of its use in patients with cystic fibrosis","volume":"73","author":"Deeks","year":"2013","journal-title":"Drugs"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1002\/ppul.25627","article-title":"Review of CFTR modulators 2020","volume":"56","author":"Goetz","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor-ivacaftor in residual-function heterozygotes with cystic fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N Engl J Med"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N Engl J Med"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1164\/rccm.202102-0509OC","article-title":"A phase 3 open-label study of Elexacaftor\/Tezacaftor\/Ivacaftor in children 6 through 11 years of age with cystic fibrosis and at least one F508del allele","volume":"203","author":"Zemanick","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.202301-0084OC","article-title":"Phase 3 open-label clinical trial of elexacaftor\/tezacaftor\/ivacaftor in children aged 2 through 5 years with cystic fibrosis and at least one F508del allele","volume":"208","author":"Goralski","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jcf.2021.09.010","article-title":"CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis","volume":"21","author":"Gould","year":"2022","journal-title":"J Cyst Fibros"},{"key":"R57-20250730","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.02.013","article-title":"Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators","author":"Sadras","year":"2023","journal-title":"J Cyst Fibros"},{"key":"R58-20250730","first-page":"35","article-title":"Left behind: the potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis","volume":"42","author":"McGarry","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MCP.0000000000000821","article-title":"Telehealth and virtual health monitoring in cystic fibrosis","volume":"27","author":"Vagg","year":"2021","journal-title":"Curr Opin Pulm Med"},{"issue":"(Suppl 3)","key":"R60-20250730","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jcf.2021.08.028","article-title":"Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic","volume":"20","author":"Dowd","year":"2021","journal-title":"J Cyst Fibros"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2022.07.002","article-title":"Telehealth and CFTR modulators: accelerating innovative models of cystic fibrosis care","volume":"22","author":"Prickett","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"(Suppl 3)","key":"R62-20250730","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2021.08.034","article-title":"Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs","volume":"20","author":"Gifford","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"(Suppl 3)","key":"R63-20250730","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcf.2021.09.004","article-title":"Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: a qualitative analysis of interviews with cystic fibrosis care team members","volume":"20","author":"Van Citters","year":"2021","journal-title":"J Cyst Fibros"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13052-021-00970-4","article-title":"COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients","volume":"47","author":"Servidio","year":"2021","journal-title":"Ital J Pediatr"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"23743735211008295","DOI":"10.1177\/23743735211008295","article-title":"Impact of COVID-19 lockdown on pulmonary and nutritional status in children and young adults with cystic fibrosis, in Greece","volume":"8","author":"Loukou","year":"2021","journal-title":"J Patient Exp"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/ppul.25560","article-title":"Change in CF care during COVID-19 pandemic: single-center experience in a middle-income setting","volume":"56","author":"Hatziagorou","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R67-20250730","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.03.003","article-title":"The impact of telehealth based care on paediatric cystic fibrosis outcomes","author":"Rimbaldo","year":"2023","journal-title":"J Cyst Fibros"},{"key":"R68-20250730","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00588-2021","article-title":"Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study","volume":"8","author":"Thee","year":"2022","journal-title":"ERJ Open Res"},{"issue":"(Suppl 3)","key":"R69-20250730","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2021.08.035","article-title":"Remote monitoring in telehealthcare delivery across the U.S. cystic fibrosis care network","volume":"20","author":"Ong","year":"2021","journal-title":"J Cyst Fibros"},{"key":"R70-20250730","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2021.08.013","article-title":"A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis","volume":"21","author":"Paynter","year":"2022","journal-title":"J Cyst Fibros"},{"key":"R71-20250730","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2021-001529","article-title":"Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: a quality improvement process","volume":"10","author":"Compton","year":"2021","journal-title":"BMJ Open Qual"},{"key":"R72-20250730","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0277-9536(96)00221-3","article-title":"Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango)","volume":"44","author":"Charles","year":"1997","journal-title":"Soc Sci Med"},{"key":"R73-20250730","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.acap.2015.03.011","article-title":"Shared decision making in pediatrics: a systematic review and meta-analysis","volume":"15","author":"Wyatt","year":"2015","journal-title":"Acad Pediatr"},{"key":"R74-20250730","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12875-020-01317-4","article-title":"Agenda setting and visit openings in primary care visits involving patients taking opioids for chronic pain","volume":"22","author":"Hood-Medland","year":"2021","journal-title":"BMC Fam Pract"},{"key":"R75-20250730","first-page":"CD012578","article-title":"Interventions for promoting participation in shared decision-making for children and adolescents with cystic fibrosis","volume":"5","author":"Malone","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R76-20250730","doi-asserted-by":"crossref","first-page":"23743735211034032","DOI":"10.1177\/23743735211034032","article-title":"Assessing shared decision-making in cystic fibrosis care using collaboRATE: a cross-sectional study of 159 programs","volume":"8","author":"Homa","year":"2021","journal-title":"J Patient Exp"},{"key":"R77-20250730","doi-asserted-by":"crossref","first-page":"2381468317715621","DOI":"10.1177\/2381468317715621","article-title":"Shared decision-making tool for self-management of home therapies for patients with cystic fibrosis","volume":"2","author":"Eckman","year":"2017","journal-title":"MDM Policy Pract"},{"key":"R78-20250730","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/journalofethics.2017.19.11.pfor1-1711","article-title":"Using principles of co-production to improve patient care and enhance value","volume":"19","author":"Turakhia","year":"2017","journal-title":"AMA J Ethics"},{"key":"R79-20250730","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ppul.24655","article-title":"Clinical communication preferences in cystic fibrosis and strategies to optimize care","volume":"55","author":"Cooley","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"R80-20250730","doi-asserted-by":"crossref","first-page":"e17875","DOI":"10.2196\/17875","article-title":"Patient and family participation in clinical guidelines development: the Cystic Fibrosis Foundation Experience","volume":"12","author":"Hempstead","year":"2020","journal-title":"J Particip Med"},{"issue":"(Suppl 1)","key":"R81-20250730","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmjqs-2013-002782","article-title":"The interdependent roles of patients, families and professionals in cystic fibrosis: a system for the coproduction of healthcare and its improvement","volume":"23","author":"Sabadosa","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"R82-20250730","article-title":"Establishing a Cystic Fibrosis Learning Network: interventions to promote collaboration and data-driven improvement at scale","author":"Ong","year":"2022","journal-title":"Learning Health Syst"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:02:36Z","timestamp":1753898556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001286","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]}}}